• Aucun résultat trouvé

Challenges in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan, Côte d'Ivoire

N/A
N/A
Protected

Academic year: 2021

Partager "Challenges in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan, Côte d'Ivoire"

Copied!
3
0
0

Texte intégral

(1)

HAL Id: inserm-00668444

https://www.hal.inserm.fr/inserm-00668444

Submitted on 9 Feb 2012

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Challenges in integrating cervical cancer screening in

HIV care clinics in West Africa: a pilot study in

Abidjan, Côte d’Ivoire

Apollinaire Horo, Antoine Jaquet, Badian Toure, Didier Ekouevi, Séverin

Lenaud, Benjamin Effi, Annie Sasco, Eugene Messou, Emmanuel Bissagniene,

Mamourou Kone, et al.

To cite this version:

Apollinaire Horo, Antoine Jaquet, Badian Toure, Didier Ekouevi, Séverin Lenaud, et al.. Challenges

in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan,

Côte d’Ivoire. 12th International Conference on Malignancies in AIDS and Other Acquired

Immun-odeficiencies (ICMAOI), Apr 2010, Bethesda, United States. pp.A10, �10.1186/1750-9378-5-S1-A10�.

�inserm-00668444�

(2)

M E E T I N G A B S T R A C T S

Open Access

Challenges in integrating cervical cancer

screening in HIV care clinics in West Africa:

a pilot study in Abidjan, Côte d

’Ivoire

Apollinaire Horo

1

, Antoine Jaquet

2*

, Badian Toure

1

, Didier K Ekouevi

2,3,4

, Séverin Lenaud

4

, Benjamin Effi

5

,

Annie J Sasco

2

, Eugene Messou

6

, Emmanuel Bissagniene

7

, Mamourou Kone

1

, François Dabis

2

From 12

th

International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies

(ICMAOI)

Bethesda, MD, USA. 26-27 April, 2010

Background

The ongoing scale-up of antiretroviral therapy (ART) in low-resource settings continues to improve the prog-nosis of HIV-infected individuals, necessitating a focus on long-term case management especially in women. Facing the particularly high burden of cervical cancer in sub-Saharan Africa, preventive measures are therefore becoming an integral component of a comprehensive approach to the management of patients. We describe here some of the operational aspects of a cervical cancer screening procedure based on visual inspection among HIV-positive women attending ART clinics in Abidjan.

Methods

A cross-sectional study is being conducted in two HIV clinics of Abidjan, since August 2009. A mobile team composed of three trained midwives and a senior gyne-cologist is in charge of proposing cervical screening based on visual inspection to all HIV-infected women attending participating clinics. Midwives are in charge to perform visual inspection of the cervix with acetic acid (IVA) and lugol’s iodine (IVL). Exclusion criteria are following: no previous cervical cancer or total hys-terectomy, aged <25 or >59 years, pregnancy over 20 weeks. They refer positively screened women (IVA+ or IVL+), to a gynecologist in charge of the colposcopy examination (and biopsy if needed). Women with con-firmed lesions are proposed an adapted treatment according to local available resources.

Results

Of the first 1,653 HIV-positive women, who attended the cervical screening consultations, 49 were not eligible and 103 were not assessable because of a prevalent cer-vical infection. The median age of the 1,501 screened women was 37 (IQR 32-43) years, and 1171 (78%) were on ART. 133 (9%) women were positively screened for cervical pre malignancy and referred for medical exami-nation. 69 (4.6%, 95% CI 3.5-5.6) were confirmed by col-posocopy and had histological investigation. Results of the 69 biopsy performed were as follows; 48 cervical intraepithelial neoplasia (CIN) of grade 1, 8 CIN grade 2 or 3, 2 invasive carcinoma and 10 nonmalignant find-ings. 22 patients were treated with cryotherapy, 16 were referred for surgical excision, and 31 were proposed a gynecological followup.

Conclusion

Several barriers were identified as limiting the ability of visual inspection used as a cervical screening method such as a high rate of cervical infection or a high rate of false-positive cervical lesions. Health care systems in West African countries cannot afford the financial and structural burdens of a conventional cervical screening program. Strategies adapted to HIV-infected women and relying on visual inspection appear feasible despite stated limitations and should be further evaluated.

Acknowledgements

This abstract is being submitted on behalf of the International Epidemiological Database to Evaluate AIDS in West Africa collaboration. This article has been published as part of Infectious Agents and Cancer Volume 5 Supplement 1, 2010: Proceedings of the 12thInternational *Correspondence: antoine.jaquet@isped.u-bordeaux2.fr

2INSERM CRE U 897, ISPED, Université Victor Segalen, Bordeaux, France

Full list of author information is available at the end of the article Horo et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A10 http://www.infectagentscancer.com/content/5/S1/A10

(3)

Conference on Malignancies in AIDS and Other Acquired

Immunodeficiencies (ICMAOI). The full contents of the supplement are available online at http://www.biomedcentral.com/1750-9378/5?issue=S1. Author details

1Service de Gynécologie Obstétrique, CHU de Yopougon, Abidjan, Côte

d’Ivoire.2INSERM CRE U 897, ISPED, Université Victor Segalen, Bordeaux, France.3Clinique MTCT+ Adultes, ACONDA, Abidjan, Côte d’Ivoire. 4

Programme PAC-CI, CHU de Treichville, Abidjan, Côte d’Ivoire.5Service d’Anatomo-Pathologie, CHU de Treichville, Abidjan, Côte d’Ivoire.6CePReF,

ACONDA, Abidjan, Côte d’Ivoire.7Service de Maladies Infectieuses et

Tropicales (SMIT), CHU de Treichville, Abidjan, Côte d’Ivoire. Published: 11 October 2010

doi:10.1186/1750-9378-5-S1-A10

Cite this article as: Horo et al.: Challenges in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan, Côte d’Ivoire. Infectious Agents and Cancer 2010 5(Suppl 1):A10.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit Horo et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A10

http://www.infectagentscancer.com/content/5/S1/A10

Références

Documents relatifs

Children from families where one or more adults are HIV-infected are more likely than children in non-affected households to be withdrawn from school because

The present study addressed the psychosocial needs of women at a high genetic risk of BC undergoing genetic counseling in French and German cancer genetic clinics in order to

The WHO country mission will evaluate the HIV treatment and care programme in Georgia along the cascade of care and services and will provide recommendations on: standardisation

In Africa, several issues and challenges exist when dealing with cervical cancer prevention and control – Lack of cervical cancer control policy, strategies and programmes; Lack

OBJECTIVE To determine the rate of cervical screening among HIV-positive women who received care at a tertiary care clinic, and to determine whether screening rates were

Screening history is measured by the percentage of women diagnosed with invasive cervical cancer whose last Pap test was six months to less than three years, three to fi ve years,

• In evaluating screening methods, many of the studies reviewed here concluded that HPV DNA testing alone should eventually become the primary test in women aged 30 years or older

In 1999, five international health organizations came to- gether to create the Alliance for Cervical Cancer Prevention (ACCP).* For the next eight years, with support from the